RFL — Rafael Holdings, Inc.

—
NYSE · Health Care · Pharmaceuticals · CIK 1713863 ·
Last close
$0.91
Market Cap
$46.95M
52W High
$3.96
52W Low
$0.89
ADV30
64,931
Next earnings
2026-12-10

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jul 2026 244,000 231,000 -9,731,000 -9,176,000 83,055,000 22,074,000 11,085,000
Apr 2026 179,000 171,000 -6,870,000 -4,226,000 91,990,000 30,497,000 11,187,000
Jan 2026 211,000 199,000 -6,655,000 -6,417,000 99,315,000 37,779,000 16,057,000
Oct 2025 240,000 231,000 -10,141,000 -9,816,000 105,375,000 45,539,000 16,195,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-29,987,000
Investing CF
$-676,000
Financing CF
$-116,000
CapEx
—
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.59
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-261,898,000
Inventory
$377,000
Receivables
$444,000
ST Investments
$0
EBIT TTM
$-27,622,000
Pretax Income TTM
$-27,955,000
Interest Exp TTM
$333,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$874,000
EBITDA
$-33,205,000
Free Cash Flow
$-20,674,000
Enterprise Value
$40,551,876
Total Cash
$22,074,000
Total Debt
$610,000
Shares Out
51,397,436
Trailing EPS
$-0.58
Book Value
$1.27
ROE
-32.8%
ROA
-21.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jul 2026 874,000 -33,409,000 -29,635,000 83,055,000 11,085,000 66,309,000 -29,987,000
Jul 2025 — — — — — — —
Jul 2024 637,000 -102,627,000 -34,410,000 96,832,000 10,574,000 82,185,000 -7,802,000
Jul 2023 279,000 -15,043,000 -1,876,000 98,829,000 2,200,000 100,293,000 -10,886,000
Jul 2022 410,000 -60,477,000 -124,658,000 118,320,000 21,114,000 100,515,000 -26,079,000

TTM Snapshot

Revenues TTM
$980,000
NetIncome TTM
$-32,553,000
OpCashFlow TTM
—
Assets (Latest)
$91,990,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
CLNN Clene Inc. $46.37M $3.22 —
SMNR Semnur Pharmaceuticals, Inc. $46.04M $0.20 —
NMAD NOMAD POWER SOLUTIONS, INC. $48.30M $3.00 —
APLM Apollomics Inc. $49.09M $16.84 —
PDSB PDS Biotechnology Corp $50.03M $0.89 —

News headlines (Yahoo Finance, 1h cache)

Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
2026-11-03 16:14 · Yahoo
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update
2026-10-29 12:00 · Yahoo
Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
2026-10-29 11:00 · Yahoo
Rafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing
2026-10-04 06:01 · Yahoo
Cyclo goes forth with Niemann-Pick drug’s approval bid despite Phase III miss
2026-10-01 13:49 · Yahoo
Rafael Holdings Shares Fall 25% After Trappsol Cyclo Phase 3 Trial Misses Primary Endpoint
2026-09-30 13:49 · Yahoo
Rafael Holdings stock tumbles 25% as drug trial misses goal
2026-09-30 13:47 · Yahoo
Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
2026-09-30 11:00 · Yahoo
Rafael Holdings Insider Ups Holding By 1,810% During Year
2026-04-28 14:26 · Yahoo
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
2026-06-11 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.